耐受性
丁丙诺啡
医学
药代动力学
生物利用度
交叉研究
麻醉
生物等效性
药理学
舌下给药
类阿片
内科学
不利影响
安慰剂
替代医学
受体
病理
作者
Stephen Chin Beng Lim,Stephan A. Schug,Janakan Krishnarajah
出处
期刊:Pain Medicine
[Oxford University Press]
日期:2017-11-28
卷期号:20 (1): 143-152
被引量:14
摘要
Buprenorphine is approved for use in pain management and opioid addiction. Sublingual administration of buprenorphine is a simple and noninvasive route of administration and has been available for many years. Improved sublingual formulations may lead to increased utilization of this useful drug for acute and chronic pain management.
科研通智能强力驱动
Strongly Powered by AbleSci AI